ApconiX

Delighted to share our recent paper in Drug Discovery Today describing Drug Discovery at UOB. Well done to the authoring team! @unibirm_MDS @LES_UniBham @eps_unibham @ITMBirmingham @unibirm_MDS doi.org/10.1016/j.drud…

Excellent presentation from Dr Angie Murray on the Birmingham Drug Discovery Hub at the @unibirmingham Translational Research Day

We welcomed PhD student, Courtney Riley, to the ApconiX laboratory with her supervisor, Dr Jacobo Elies Gomez, from the University of Bradford. Courtney will spend up to 6 months in the ApconiX ion channel laboratory during her PhD. #drugdiscovery

Dr Sean Hammond will be presenting "Immune Checkpoint Inhibitors and Compound Hypersensitivity: An Emerging Immunological drug-drug interaction?" at the event organised by Immundnz Ltd. at Alderley Park tomorrow. The 1 day event is free to attend. #drugdiscovery

We are delighted that Dr Kimberly Rockley has been shortlisted for the Bionow Rising Star Award 2022. Fingers crossed for the 16th of March. Good luck to all the other candidates Laura Ajram, Michael Eyres Medicines Discovery Catapult and John Forsey @PharmaronBio

bit.ly/ApconiXSarah - ApconiX is delighted to welcome Sarah Pass who joins the team of nonclinical DMPK experts and will be working with Dr Richard Knight. #DrugDiscovery

bit.ly/ApconiXScott - ApconiX is delighted to welcome Scott Hackford who joins the team of nonclinical safety experts working with Dr Richard Knight. Scott has over 12 years’ experience in a contract research organisation as a study director and lead toxicologist.

Outstanding ⁦@HESI_Global⁩ board meeting with our exceptional global team of scientists. linkedin.com/posts/activity…

bit.ly/ApconiXBulleti… - Drug Safety Bulletin - a quarterly update of pharma safety news selected by ApconiX #drugdiscovery

bit.ly/ApconiXMichelle ApconiX is delighted to welcome Michelle Blissett to the team. Michelle has joined the target safety assessment team and will be working alongside Dr James Sidaway and Professor Ruth Roberts.

Recently published by co-authors Xiaoli Meng, Merrie Mosedale, Dean Naisbitt and Sean Hammond in Toxicology Letters, a third in the series of reports sciencedirect.com/science/articl….

We are delighted to announce the promotion of Dr Laurence Bishop to Deputy Director. Laurence joined us in May 2020 and has helped us to significantly expand our client base. As a key part of the ApconiX leadership, we thank him for his contribution.

Hoping everyone has a lovely holiday and all the very best for 2023 😁

Julie Knight has retired from ApconiX. A very sad day. She will be very badly missed by the whole team. Julie is looking forward to new horizons and though no longer working for us she will not be too far away. We all wish Julie the very best of luck!

A lovely time was had at the ApconiX Christmas do...and there's lots of photos 😀...bit.ly/ApconiXXmas22 #DrugDiscovery

bit.ly/ApconiXAwards The Pharmacology and Therapeutics Department of the University of Liverpool held a Postgraduate Seminar Day on the December 12th, 2022, at the Radisson Blu in Old Hall Street Liverpool ApconiX was delighted to sponsor two awards #drugdiscovery

bit.ly/ApconiXAmy ApconiX is delighted to welcome Dr Amy Shepherd is an experienced immunologist who joins the team of nonclinical safety experts and will be working with Dr Richard Knight #drugdiscovery

What a day! We won the Alderley Park Christmas Quiz Night too! Hannah Jennings, Richard Knight, Ruth Roberts, Will Humfrey, Laurence Bishop, Henry Bushell and Bethan Kelly 😁 #drugdiscovery

bit.ly/ApconiXWill ApconiX is delighted to welcome William Humfrey who joins the Acuity Target Safety Assessment team working with Professor Ruth Roberts and Dr James Sidaway #drugdiscovery

The Christmas tree is up complete with a Fat Cell angel (limbering up for the Christmas do!), the three wise cells (Buddy, Cap'n T-Cell and Den Dritric) and miscellaneous "stable" animals (llama, panda and axolotl)! Many thanks to Miltenyi Biotec for the happycells